Exelixis Inc (NASDAQ:EXEL)

3.49
Delayed Data
As of Jul 01
 -0.27 / -7.18%
Today’s Change
1.26
Today|||52-Week Range
4.55
+142.36%
Year-to-Date

Today’s Trading

Previous close3.76
Today’s open3.60
Day’s range3.38 - 3.71
Volume4,620,770
Average volume (3 months)3,278,685
Market cap$736.7M
Dividend yield--
Data as of 4:00pm ET, 07/01/2015

Growth & Valuation

Earnings growth (last year)-3.76%
Earnings growth (this year)+41.43%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-19.87%
P/E ratioNM
Price/Sales11.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-0.93-8.39%
AMRIAlbany Molecular Res...-0.47-2.32%
LXRXLexicon Pharmaceutic...-0.04-0.50%
NXTMNxStage Medical Inc+0.21+1.44%
Data as of 4:00pm ET, 07/01/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$25.1M
Annual profit (last year)-$268.5M
Net profit margin-1,069.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers